News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,431 Results
Type
Article (41605)
Company Profile (279)
Press Release (674543)
Multimedia
Podcasts (73)
Webinars (15)
Section
Business (206843)
Career Advice (2017)
Deals (35844)
Drug Delivery (100)
Drug Development (82621)
Employer Resources (172)
FDA (16456)
Job Trends (15058)
News (350021)
Policy (32942)
Tag
Academia (2601)
Accelerated approval (14)
Adcomms (26)
Allergies (101)
Alliances (50433)
ALS (116)
Alzheimer's disease (1499)
Antibody-drug conjugate (ADC) (174)
Approvals (16467)
Artificial intelligence (349)
Autoimmune disease (31)
Automation (22)
Bankruptcy (362)
Best Places to Work (11787)
BIOSECURE Act (19)
Biosimilars (128)
Biotechnology (199)
Bladder cancer (107)
Brain cancer (41)
Breast cancer (399)
Cancer (3168)
Cardiovascular disease (227)
Career advice (1688)
Career pathing (30)
CAR-T (203)
CDC (34)
Cell therapy (540)
Cervical cancer (25)
Clinical research (68291)
Collaboration (1117)
Company closure (4)
Compensation (774)
Complete response letters (30)
COVID-19 (2658)
CRISPR (63)
C-suite (398)
Cystic fibrosis (118)
Data (3291)
Decentralized trials (2)
Denatured (22)
Depression (68)
Diabetes (358)
Diagnostics (6546)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (157)
Drug pricing (132)
Drug shortages (28)
Duchenne muscular dystrophy (159)
Earnings (89047)
Editorial (44)
Employer branding (21)
Employer resources (148)
Events (116201)
Executive appointments (909)
FDA (18430)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (995)
Gene editing (140)
Generative AI (28)
Gene therapy (413)
GLP-1 (825)
Government (4587)
Grass and pollen (6)
Guidances (320)
Healthcare (19111)
HIV (42)
Huntington's disease (30)
IgA nephropathy (43)
Immunology and inflammation (165)
Immuno-oncology (13)
Indications (42)
Infectious disease (2844)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (72)
Intellectual property (134)
Interviews (312)
IPO (16765)
IRA (48)
Job creations (3668)
Job search strategy (1429)
Kidney cancer (14)
Labor market (57)
Layoffs (527)
Leadership (19)
Legal (7976)
Liver cancer (85)
Longevity (11)
Lung cancer (443)
Lymphoma (226)
Machine learning (15)
Management (58)
Manufacturing (443)
MASH (97)
Medical device (13576)
Medtech (13587)
Mergers & acquisitions (19852)
Metabolic disorders (887)
Multiple sclerosis (103)
NASH (17)
Neurodegenerative disease (137)
Neuropsychiatric disorders (37)
Neuroscience (2243)
NextGen: Class of 2025 (6590)
Non-profit (4533)
Now hiring (50)
Obesity (443)
Opinion (230)
Ovarian cancer (107)
Pain (119)
Pancreatic cancer (134)
Parkinson's disease (197)
Partnered (23)
Patents (334)
Patient recruitment (197)
Peanut (50)
People (58628)
Pharmaceutical (68)
Pharmacy benefit managers (21)
Phase I (21331)
Phase II (30050)
Phase III (22416)
Pipeline (2077)
Policy (219)
Postmarket research (2599)
Preclinical (9065)
Press Release (64)
Prostate cancer (155)
Psychedelics (39)
Radiopharmaceuticals (267)
Rare diseases (487)
Real estate (5981)
Recruiting (66)
Regulatory (23111)
Reports (50)
Research institute (2383)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (11)
RSV (54)
Schizophrenia (102)
Series A (163)
Series B (119)
Service/supplier (11)
Sickle cell disease (64)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (33)
Startups (3662)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (66)
The Weekly (49)
Vaccines (832)
Venture capital (58)
Weight loss (275)
Women's health (48)
Worklife (16)
Date
Today (143)
Last 7 days (736)
Last 30 days (2410)
Last 365 days (31744)
2025 (19552)
2024 (35830)
2023 (40562)
2022 (51764)
2021 (56297)
2020 (54613)
2019 (47121)
2018 (35505)
2017 (32701)
2016 (32069)
2015 (38109)
2014 (31793)
2013 (26753)
2012 (28953)
2011 (29683)
2010 (27642)
Location
Africa (734)
Alabama (69)
Alaska (7)
Arizona (248)
Arkansas (13)
Asia (39159)
Australia (6388)
California (8071)
Canada (2487)
China (722)
Colorado (340)
Connecticut (353)
Delaware (209)
Europe (85518)
Florida (1214)
Georgia (267)
Hawaii (2)
Idaho (61)
Illinois (683)
India (30)
Indiana (384)
Iowa (18)
Japan (246)
Kansas (112)
Kentucky (31)
Louisiana (16)
Maine (64)
Maryland (1106)
Massachusetts (6058)
Michigan (253)
Minnesota (490)
Mississippi (4)
Missouri (98)
Montana (30)
Nebraska (25)
Nevada (88)
New Hampshire (68)
New Jersey (2240)
New Mexico (28)
New York (2229)
North Carolina (1135)
North Dakota (10)
Northern California (3587)
Ohio (252)
Oklahoma (16)
Oregon (34)
Pennsylvania (1741)
Puerto Rico (17)
Rhode Island (38)
South America (1110)
South Carolina (36)
South Dakota (1)
Southern California (3064)
Tennessee (135)
Texas (1216)
United States (29791)
Utah (233)
Virginia (200)
Washington D.C. (75)
Washington State (667)
West Virginia (4)
Wisconsin (82)
716,431 Results for "f1 oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
August 13, 2025
·
8 min read
Press Releases
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
June 10, 2025
·
4 min read
Sponsored
Bridging the Gap: Aligning Drug Development with Real-World Clinical Needs in Oncology
In the United States, only 31.4 % of phase II/III clinical trials in oncology are successfully completed
1
. The causes of this dramatic economic and time-consuming loss are, among others, protocol design and patient recruitment challenges.
July 7, 2025
·
6 min read
Press Releases
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 2, 2025
·
4 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Acceptance of Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29, 2025
·
2 min read
Earnings
J&J Targets $50B Oncology Sales By 2030: Updated
Johnson & Johnson’s $23.7 billion in second-quarter earnings, driven by cancer and neuroscience drugs, exceeded analyst expectations, while CEO Joaquin Duato set a target of $50 billion in oncology sales by 2030.
July 16, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
9 min read
Press Releases
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 29, 2025
·
4 min read
Press Releases
NorthSea Therapeutics Announces Publication of Positive Results from Phase 2b ICONA Clinical Trial of Icosabutate in Biopsy-Confirmed F1-F3 MASH in Journal of Hepatology
March 6, 2025
·
6 min read
Press Releases
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody
May 21, 2025
·
5 min read
1 of 71,644
Next
